Common Markers and Bacterial Signatures in Health and Disease
Researchers have identified repeating patterns and bacterial signatures across numerous conditions. While the microbiome is individualized, several consistent trends emerge when comparing healthy and diseased populations. Below we summarize key patterns linked to major disease categories and highlight representative markers.
Inflammatory bowel disease (IBD)
IBD, including Crohn's disease and ulcerative colitis, is one of the best-studied conditions in microbiome research. Typical signatures include:
These markers often correlate with disease activity and mucosal inflammation, and some therapeutic strategies aim to restore SCFA producers to promote mucosal healing.
Metabolic disorders: obesity and type 2 diabetes
Microbial patterns associated with metabolic disease are complex and context-dependent but frequently include:
Interventions like dietary change, prebiotics, and targeted probiotics can shift these signatures and improve metabolic parameters in some individuals.
Colorectal cancer (CRC)
Multiple studies have highlighted microbiome-based markers for CRC risk and early detection. Representative features include:
Microbiome-based screening panels are an active area of research for non-invasive CRC detection and risk stratification.
Neurological and psychiatric conditions
The gut-brain axis links microbial activity to neural function via immune, neural, endocrine, and metabolic pathways. Signatures observed in conditions such as autism spectrum disorder, depression, and Parkinson's disease include:
While fascinating mechanistic links exist, clinical translation in neuropsychiatry is still emerging due to heterogeneity and reproducibility challenges.
Immune-mediated and allergy-related patterns
Early-life microbial exposures shape immune development. Patterns linked to allergic disease and asthma often include:
Interventions in infancy that modulate these markers show promise for allergy prevention in some trials.
Common cross-cutting markers
Across many conditions, several cross-cutting features recur as potential general markers of poor gut health:
These shared patterns suggest that restoring core functions and resilience may be a unifying therapeutic goal across diseases. The next section focuses on clinical applications: how these markers are used for diagnosis, prognosis, and guiding therapy.